Industry Leaders Outlook on the Future of Healthcare

BY: BRETT JOHNSON, EDITOR-IN-CHIEF “Value-driven” vs. “volume-driven” was the theme of a discussion between top management of the country’s important […]

Read more »

NanoViricides Opens New Facility in Shelton, CT for Production of Drug Candidates

NanoViricides, Inc. (NYSE MKT:NNVC) opened its new R&D and cGMP pilot manufacturing facility with U.S. Congressman Jim Himes performing the ribbon cutting to inaugurate the facility on July 21, 2014.

NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. The company’s novel nanoviricide® class of drug candidates is designed to specifically attack enveloped virus particles and dismantle them.

Read more »

The Whirl of Wound Care

However irksome it may be to think about open or healing wounds, the medical advances and market potential in this niche space is quite appealing for investors. Globally, there are 50 million reported cases of patients suffering from some type of wound that may be difficult to close or heal.

Read more »

“Corporate Governance Gap” InVivo (NVIV) Delays Listing to National Securities Exchange “Postponed”; Amarantus BioScience (AMBS) DTC Chill Lifted. What is the Next Step for Corporate Governance in the Biotechnology Sector?

Recent challenges to biotechnology companies have been in the form of corporate governance issues, especially those undergoing rapid growth.  Two […]

Read more »

Editor’s Note, October 24, 2013

Dear Subscriber, In the coming weeks we will be providing short profiles of selected companies presenting at the 7th Annual […]

Read more »

“The Value Proposition of the JOBS Act and Reg A” How Will Capital Market Structures Assess Valuation for Smaller Medical Technology Companies After the JOBS Act?

There has been much debate of how the capital market landscape is looking to shape up for bioscience companies with […]

Read more »

Metabiomics’ Exec: Test Can Be a Cheaper and More Accurate Alternative to Colonoscopies

Metabiomics is developing a noninvasive screening test for colon polyps in colorectal cancer based on human microbiome markers. In an interview with OneMedRadio, Gregory Kuehn, Vice President of Business Development at Metabiomics, explained that the preliminary data showed “sensitivity in excess of 97%” and specificity “as high as 93%.” Metabiomics will present at the upcoming OneMedForumNY 2013 on June 27th.

Read more »

Aptiv Solutions Executive Discusses the State of Mobile Health Technology Regulatory

OneMedRadio spoke with Cynthia Nolte, Director, Medical Device Regulatory Services for Aptiv Solutions, about the state of mobile health/health information technology regulatory, clinical trial design for mobile health technology, and what we can expect from future guidelines. The conclusions about regulating a rapidly evolving space — and the case studies that have pioneered this process — are intriguing, and indeed promising.

Read more »

Editor’s Note: June 6, 2013

Less than one month away from OneMedForumNY 2013, June 26-27 in New York City. We are excited to announce our […]

Read more »

Medical Services Companies Showing Strong Earnings

Healthcare has been one of the hottest sectors over the past year. This can be seen by looking at various ETFs such as iShares Dow Jones US Healthcare (IYH). This particular ETF has appreciated by approximately 35% over the past 52 weeks which is significantly higher than the 27% appreciation that the S&P Depository Receipts (SPY) has given investors. Now the healthcare sector is built up of many smaller industries and this article will focus on medical services companies which have produced strong quarterly results.

Read more »